
We are recruiting for an outstanding clinical/translational leader and physician to serve as Section Chief, Thoracic Medical Oncology - contact me if interested @Perlmutter_CC @nyulangone @nyugrossman apply.interfolio.com/164896

We combine visionary thinking and compassionate care with the science of treating cancer. An NCI-designated Comprehensive Cancer Center, part of @NYULangone

We are recruiting for an outstanding clinical/translational leader and physician to serve as Section Chief, Thoracic Medical Oncology - contact me if interested @Perlmutter_CC @nyulangone @nyugrossman apply.interfolio.com/164896

Really excited about the stellar team of lymphoma clinical and translational researchers we have developed across our system @Perlmutter_CC @nyugrossman @nyulangone physicianfocus.nyulangone.or…

Only one week to go for #chromatin2026! The countdown is officially on, and we can’t wait to welcome everyone to this year’s symposium. See you there! Recorded talks will be available to those who register after the day. nyulangone.zoom.us/webinar/r… #chromatin2026

WATCH 👀: @ElaineShumMD of @nyulangone discusses biomarker testing and oncogenic drivers in lung cancer at NY Lung #oncology #lcsm

Wrapping up #SNO2026, @nyulangone presenters will explore drug delivery, intraoperative molecular classification, liquid biopsy and radiopharmaceutical therapy—advancing and expanding what’s possible in #NeuroOncology. Learn more ➡️ bit.ly/4BM5N2e @DanOrringerMD

This week, 1st-yr fellow Dr. @calvin__ludwig taught on-service @BellevueHosp housestaff re high-yield AML concepts, including initial workup, differentiating APL, induction, consolidation, and indications for BMT. #oncology #hematology #leukemia #MedEd @Perlmutter_CC

So proud of Peter Martin receiving the Distinguished Leadership Award from @lymphoma fun night with our @Perlmutter_CC @nyugrossman @nyulangone team and over $2 million raised for the foundation!

Today at #SNO2026: Dr. Alexandra Miller highlights research on CSF liquid biopsy, glioma evolution & molecular testing, exploring less invasive approaches to monitor brain tumors and guide treatment decisions. See all @NYULangone presentations➡️ bit.ly/4BM5N2e

Join Mary Rzeszut, DSW, LCSW, for a workshop that offers cancer patient caregivers practical, evidence-informed strategies to promote resilience, restore energy, and sustain well-being throughout the #CancerSurvivorship journey. RSVP: bit.ly/46PRn2L

We’re proud of our Brain & Spine Tumor Center experts, who are sharing their latest research today at @NeuroOnc’ 31st Annual Society for Neuro-Oncology Annual Meeting & Education in Philadelphia! Click below to view all of today's @NYULangone presentations at #SNO2026!

Don't miss Dr. Manuel Hidalgo present on systemic therapies & outcomes in #PancreaticCancer Join us to discuss advances in liver & pancreatic cancer prevention, diagnosis & treatment ➡️GI Cancer Summit ➡️Nov 19-20 ➡️bit.ly/4e1GdMi #GICancerSummit2026 @Perlmutter_CC

What an honor to co-lead with @ketta LORUSSO and mentor @mdslightfoot on this practice changing trial. A nice win for pts with #EC with limited options. @GOG @SGO_org @myESMO @IGCSociety @Perlmutter_CC @gyncsm
To read the full publication, click link in bio or go to ow.ly/kgwU5102zFm. @BPothuri #GOGPartners #GynecologicOncology #clinicaltrials #GOGF #clinicaltrials #endometrialcancer #ESMO26

🏥 @nyulangone Perlmutter Cancer Center has appointed @VivekSubbiah, MD, Director of Early-Phase Drug Development and Rare Cancer Programs. 🩺 He brings 15+ years of experience in #PrecisionOncology and clinical research. Learn more ➡️ ascopost.com/news/november-2…

⭐️New city, new chapter, same mission 🗽 ⭐️Thrilled to have joined @nyulangone @Perlmutter_CC to lead Early Phase Drug Development and the Rare Cancer Programs. ⭐️For patients with rare cancers, #PrecisionMedicine should open the door to treatment. Expanding access to early-phase trials is how we make that real. ⭐️My work has always been tumor-agnostic. That continues here, now geography agnostic & zip code agnostic too. ⭐️Such a delight to be in NY with family. Grateful to @Aiims1742, @JohnPLeonardMD & @nyuniversity @nyulangone visionary leadership for bringing me here! ⭐️Thank you to all my friends & colleagues for the wishes & the outpouring of support🙏 @OncoAlert @oncodaily @ASCO @ASCOPost tinyurl.com/238ks5m5
🏥 @nyulangone Perlmutter Cancer Center has appointed @VivekSubbiah, MD, Director of Early-Phase Drug Development and Rare Cancer Programs. 🩺 He brings 15+ years of experience in #PrecisionOncology and clinical research. Learn more ➡️ ascopost.com/news/november-2…

At #SNO2026, our neuro-oncology experts will share research and clinical insights on brain tumors, molecular diagnostics, brain mapping, and emerging approaches to treatment. See the full list of @nyulangone physicians participating ➡️ bit.ly/4BM5N2e

Coming up at 3pm East, join @DrMarcSiegel as he talks with Medical Director of the Cellular Therapy Service @samyamshon & Director of Neuro-Oncology Research, Dr. J. Ricardo McFaline-Figueroa of @Perlmutter_CC. Stream LIVE here: sxm.app.link/DoctorRadio